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Alzheimer’s disease (AD) is a heterogeneous neurodegenerative disease. Recent studies
employing microRNA-seq and genome-wide sequencing have identified some non-
coding RNAs that are influentially involved in AD pathogenesis. Non-coding RNAs
can compete with other endogenous RNAs by microRNA response elements (MREs)
and manipulate biological processes, such as tumorigenesis. However, only a few
non-coding RNAs have been reported in the pathogenesis of AD. In this study, we
constructed the first competing endogenous RNA (ceRNA) network leveraging whole
transcriptome sequencing and a previously studied microRNA-seq of APPswe/PS11E9
transgenic mice. The underlying mechanisms for the involvement of ceRNA in AD were
validated using the Dual Luciferase Reporter Assay, detection of transcription levels
by quantitative RT-PCR and translation levels by Western blotting, and morphological
examination in primary cultured neurons. In the ceRNA network, four lncRNAs
(C030034L19Rik, Rpph1, A830012C17Rik, and Gm15477) and five miRNAs (miR-
182-5p, miR-330-5p, miR-326-3p, miR-132-3p, and miR-484) are enriched in nine
pathways and an AD-related gene pool. Among them, Ribonuclease P RNA component
H1 (Rpph1) is upregulated in the cortex of APPswe/PS11E9 mice compared to
wild type controls. Rpph1 binds to miR326-3p/miR-330-5p and causes the release
of their downstream target Cdc42, which leads to CDC42 upregulation. This effect
was disrupted upon mutation of the MRE on Rpph1. Moreover, overexpression of
Rpph1 increased dendritic spine density in primary cultured hippocampal pyramidal
neurons, whereas knocking down of Rpph1 had the reverse effect. In conclusion,
Rpph1 modulates CDC42 expression level in a ceRNA-dependent manner, which may
represent a compensatory mechanism in the early stage of the AD pathogenesis.
Keywords: Alzheimer’s disease (AD), competing endogenous RNA (ceRNAs), ribonuclease P RNA component H1
(Rpph1), miR-330-5p, CDC42, spine formation
Abbreviations: AD, Alzheimer’s disease; Aβ, beta amyloid peptide; CDC42, cell division cycle 42; LncRNA, long non-coding
RNAs; MiR, MicroRNA; MREs, microRNA response elements; Rpph1, ribonuclease P RNA component H1; RISC, RNA-
induced silencing complex.
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INTRODUCTION
Alzheimer’s disease is the most common cause of dementia and
is the fifth leading cause of deaths in Americans over 65 years
of age (Alzheimer’s Association, 2015). Genetic heterogeneity, life
style and environmental factors all contribute to the development
of this disease, with the formation of amyloid β (Aβ) plague
being one of the hallmarks of AD pathology (Hardy and Selkoe,
2002; Mattson, 2004; Karch et al., 2014). However, the genetic
basis of AD in humans remains largely unknown. Genome-wide
sequencing studies have shown that protein coding genes only
occupy approximately 2% of the total genes in the human genome
(Salmena et al., 2011). Numerous non-coding genes, such as
LncRNAs, microRNAs (miRNAs, miRs) and piRNAs, may also
orchestrate the initiation and progression of AD in humans
(Okazaki et al., 2002; Guttman et al., 2009; Mercer et al., 2009;
Necsulea et al., 2014; Tay et al., 2014).
Long non-coding RNA was first described in 2002 and is
defined as an RNA transcript longer than 200 nucleotides with
no protein product (Okazaki et al., 2002). As one of the lncRNAs,
Rpph1 is well-known as an RNA subunit of RNase P, which
participates in tRNA maturation (Evans et al., 2006) and has
sometimes served as a reference gene (Soler-Alfonso et al., 2014).
Surprisingly, Rpph1 was differentially expressed in gastric cancer
(Xia et al., 2014) and neocortical tissues of seizure patients
(Lipovich et al., 2012). Therefore, Rpph1 is unlikely to act merely
as a “house-keeping enzyme” (Jarrous and Reiner, 2007), but its
functions remain elusive. MiRNAs are 19–24 nucleotides single-
stranded RNA that bind to target mRNAs and either silence or
degrade their targets by recruiting the RISC (Gregory et al., 2005;
Esteller, 2011). Considerable evidences have shown that miRNAs
are actively involved in tumorigenesis and AD pathogenesis (He
and Hannon, 2004; Kefas et al., 2009; Lee et al., 2009; Jeyapalan
et al., 2011; Li et al., 2013; Luo et al., 2014). The competing
endogenous RNA (ceRNA) hypothesis suggests that RNAs can
crosstalk by binding to miRNAs through MREs and thereby
prevent miRNAs from binding to their target mRNAs (Salmena
et al., 2011). The ceRNA theory has been proven true in the
development of cancers and AD (Poliseno et al., 2010; Jeyapalan
et al., 2011; Xia et al., 2014). For example, BACE1-AS prevents
the binding of miR-485-5p to BACE1, augments the expression of
BACE1 protein, and promotes Aβ synthesis (Faghihi et al., 2010;
Riva et al., 2016). More underlying ceRNA regulations in AD still
need to be uncovered.
Neuronal miR-326 was reported as a tumor suppressor gene
in the brain (Kefas et al., 2009), while miR-330 was reported
to suppress breast cancer and colorectal cancer development
by targeting CDC42 (Jeyapalan et al., 2011; Li et al., 2013).
CDC42 is a member of the Rho GTPase family that is responsible
for modulating actin dynamics, stimulating spinogenesis and
enlarging spine heads (Racz and Weinberg, 2008; Wegner et al.,
2008; Webb et al., 2015). Moreover, CDC42 is upregulated in
hippocampal neurons in AD patients compared to age-matched
controls (Zhu et al., 2000).
In this study, we constructed the first AD-associated ceRNA
network using data from the whole transcriptome sequencing of
the cortex of APPswe/PS11E9 transgenic mice and a previously
reported microRNA-seq database (Luo et al., 2014). Rpph1,
serving as an lncRNA hub in the ceRNA network targeting
miR-330-5p and miR-326-3p, was found to be upregulated in
APPswe/PS11E9 cortexes and hippocampi. Both miR-330-5p
and miR-326-3p were predicted to target CDC42, which is
involved in the regulation of the actin cytoskeleton pathway.
Both miR-326-3p and miR-330-5p directly bind to Rpph1. MiR-
330-5p also induces downregulation of CDC42. Furthermore,
overexpression of Rpph1 induced upregulation of CDC42 and
increased dendritic spine density, while the knocking down
of Rpph1 reduced CDC42 level and impaired dendritic spine
formation. Taken together, we now show that Rpph1 competes
with endogenous miR-330-5p and subsequently upregulates
CDC42 to modulate actin dynamics in primarily cultured
pyramidal hippocampal neurons.
MATERIALS AND METHODS
Tissue Samples and Genotyping
APPswe/PS11E9 double transgenic mice were obtained from the
Model Animal Research Center of Nanjing University (Nanjing,
China) and were originated from B6.Cg-Tg (APPswe/PS11E9)
85Dbo/Mmjax mice of The Jackson Laboratory). C57BL/6J mice
were used as wild type (WT) controls. Mice were single-housed
and bred in SPF condition IVC cages under a temperature of 23◦C
and a humidity of 50–60% with circadian rhythm illumination.
Genotyping was performed by PCR with human APP and PS1
genes, while the mouse App gene was used as an internal
control (Supplementary Figure S1; Supplementary Table S1).
Phenotyping was performed by Aβ deposition immunostaining.
Two- or twelve-month-old male mice, weighing 22–25 g, were
anesthetized with sodium pentobarbital and sacrificed by cervical
dislocation. All procedures were approved by the Animal Use and
Care Committee of Shenzhen Peking University-The Hong Kong
University of Science and Technology Medical Center (SPHMC)
(protocol number 2011-004). Tissues from three male C57BL/6J
mice aged at 2 months were used for Rpph1 expression profile
analysis.
RNA Extraction and qRT-PCR
Total RNA was extracted using TRIzol Reagent (Sigma)
according to the manufacturer’s protocol. RNA quantity was
measured using a NanoDrop 2000 (Thermo Fisher Scientific).
Quantitative RT-PCR was performed using the GoScriptTM
Reverse Transcription System (Promega) in a C1000 Thermal
Cycler (Bio-Rad). Glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) or β-actin was used as internal control. Relative
quantification of gene expression levels was calculated by 2−11Ct
method. All primers are listed in Supplementary Table S1.
Whole Transcriptome Sequencing and
Computational Analysis
RNAs from cortical tissues of two 12-month-old male
APPswe/PS11E9 mice and two age-matched male WT mice
(body weight 23–25 g) were used for whole transcriptome
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 February 2017 | Volume 10 | Article 27
fnmol-10-00027 February 6, 2017 Time: 18:32 # 3
Cai et al. Rpph1 Regulates Dendritic Spine Formation
sequencing (Jiang et al., 2012) on an Illumina HiSeq2500
platform with 100 bp paired sequence at the Shanghai Biochip
Corporation. In total, 3 µg of purified total RNA was isolated
with a ribo-zero kit, followed by strand-specific RNA seq. Briefly,
first-strand cDNA synthesis was carried out using SuperScript II
kit (Invitrogen, Carlsbad, CA, USA) in the presence of a hexamer
random primer. Second-strand cDNA was synthesized before
end-repair and dA-tailing, and DNA fragments were ligated
with a TruSeq adapter and amplified with TruSeq PCR primers
for sequencing. Reads that were longer than 35 nucleotides and
had no more than 2 N (ambiguous nucleotides) were retained.
Moreover, paired reads that mapped to the SILVA database1
were discarded. The cleaned reads of each sample were aligned
to the mouse RNA Ensembl database2 by FANSe2, allowing 7
nucleotide mismatches. All unigene clusters with at least 10
mapped reads were considered as reliable transcripts. To analyze
differentially expressed unigenes, the expression of each unigene
of different samples was converted to CPM (count per million)
by the edgeR package. Transcripts with a false discovery rate
(FDR) value lower than 0.05 and a fold change over ±1.5 were
categorized as differentially expressed. The data are accessible at
the NCBI GEO database, accession GSE87550.
ceRNA Network Construction
Construction of the ceRNA network included four steps:
(a) Differentially expressed lncRNAs in whole transcriptome
sequences were screened using a cutoff fold change ≥ ± 1.5
with an FDR < 0.05. To get better robustness and reliability of
the network, we strictly screened differentially expressed mRNA
and ncRNA with the following criteria: expression level of Gene
X was recorded for each sample: A1, A2 (APP/PS1), B1, B2
(WT). If Average (A1, A2)/Average (B1, B2) > 1.50 and if
Min (A1, A2)/Max (B1, B2) < 1, then eliminate Gene X; if
Average (A1, A2) /Average (B1, B2) < 0.67 and if Max (A1,
A2)/Min (B1, B2) > 1, then eliminate Gene X; (b) lncRNA –
miRNA interactions were predicted by the DIANA lncBase
(Paraskevopoulou et al., 2013a)3 and the following website
has the latest version: http://carolina.imis.athena-innovation.gr/
diana_tools/web/index.php?r=lncbasev2%2Findex-predicted; (c)
predicted miRNA targets with a Tpm < 10 in our previous
miRNAseq (Data accessible at NCBI GEO database, accession:
GSE55589) (Luo et al., 2014) were removed; (d) miRNA–mRNA
interactions were predicted by the DIANA web server, v5.0
(Paraskevopoulou et al., 2013b), with the support of TargetScan
and Miranda4, and TarBase v7.0 (Vlachos et al., 2015) provided
miRNA–mRNA interactions with experimental support; (e)
Predicted target mRNAs were classified by KEGG analysis with
DAVID Bioinformatics Resources 6.75 and screened in the
Alzheimer’s gene pool in GeneCards6.
1http://www.arbsilva.de/download/arbfiles/
2http://www.ensembl.org/index.html
3http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=lncPredicted/
index
4http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=MicroT_CDS/
index
5https://david.ncifcrf.gov/
6http://www.genecards.org/Search/Keyword?queryString=alzheimer
Cell Culture and Stressor Tests
Cortical and hippocampal neurons were isolated from E16–E18
mouse brains and seeded on poly-L-lysine (Sigma)-coated Petri
dishes and cultured in Neurobasal medium (Life Technologies)
containing 2% B27 (Life Technologies) at 37◦C in an incubator
with 5% CO2. For dendritic spine study, hippocampal neurons
were seeded in general medium with 10% FBS for the first 4 h,
followed by general medium replacement for further culturing.
Culture media were half-replaced every 3 days. Neuro-2a (ATCC)
and HEK 293T (ATCC) cell lines were raised in DMEM
(Life Technologies) plus 10% FBS (HyClone) and antibiotics at
37◦C in an incubator with 5% CO2. To induce differentiation,
Neuro-2a cells were grown in DMEM containing 0.5% FBS,
10 µM retinoic acid (RA) (Sigma) and antibiotics for more
than 24 h.
Stressor tests were performed with differentiated Neuro-2a
cells in differentiation medium (without RA) under the following
conditions, respectively: H2O2 (Guangzhou chemical reagent
factory, Guangzhou, China) 50 µM; glucose (Sigma) 25 mM;
amyloid beta 1–42 1 and 4 µM (Sigma); hyperthermia in a 42◦C
incubator with 5% CO2; three control sets including general
medium only, 10 µl PBS and 1 mM ammonium hydroxide. After
exposure to the indicated stressors for 12 h, cells were harvested
for RNA isolation. Aβ 1–42 was dissolved in 100µl PBS with 0.2%
ammonium hydroxide, and oligomers were prepared in a 37◦C
water bath for 12 h.
Plasmid, Reagents, and Antibodies
Wild type and mutant Rpph1 sequences were cloned into
pcDNA4a (Invitrogen) and psiCHECK2 (Promega) vectors.
MREs of miR-326-3p (5′-CCCAGAG-3′) and miR-330-3p (5′-
CCCAGAGA-3′) on Rpph1 were mutated into 5′-GCACAGAC-
3′. All plasmids were prepared in endotoxin-free conditions
by QIAGEN Plasmid Midi Kit (Qiagen) or Tiangen Plasmid
Mini Kit (Tiangen Biotech., Beijing, China). H2O2 was from
the Guangzhou chemical reagent factory, Guangzhou, China.
Glucose and Aβ 1–42 were purchased from Sigma Aldrich.
MiR-326-3p and miR-330-3p mimics were purchased from
RiboBio, Co., Ltd. (Guangzhou, China). Rabbit polyclonal
antibodies against CDC42 and β-actin were from Abcam
(ab187643) and Cell Signaling Technology (4970), respectively.
The secondary goat anti-rabbit IgG antibody (A9169) was from
Sigma.
Dual Luciferase Reporter Assay
Eighty percentage confluent HEK 293T cells were transfected
with Lipofectamine 2000 reagent (Life Technologies). Luciferase
and Renilla activity were measured by a Dual Luciferase
Reporter Assay System (Promega) at 36 h after transfection. Six
independent experiments were performed.
Transfection and RNA Interference
For the transfection of miR-326-3p, miR-330-3p, pcDNA-Rpph1-
wt and pcDNA-Rpph1-mutant into Neuro-2a cells, 4 × 105 cells
were seeded in a 35-mm dish. A 100 nM mimic or negative
control was transfected using the Lipofectamine 3000 reagent
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(Life technologies) the next day in DMEM with 10% FBS. After
12 h, the same transfection procedure was performed again.
Cells were lysed for protein collection 72 h after the second
transfection. For dendritic spine study, 1.5 × 105 dissected
hippocampal neurons were seeded into one well of a 24-well plate.
Calcium transfection was performed at DIV9 using a CalPhosTM
Mammalian Transfection Kit (Clontech). 1 µg pcDNA-Rpph1
and pcDNA vector backbone or 100 nM Rpph1 siRNA was
co-transfected with pEGFP at a molar ratio of 4:1. Cells were
fixed at DIV15. For the RNA interference study, 100 nM
Rpph1 siRNA (5′-AAGAGUGACACGCACUCAGCACGUG-3′)
was transfected into Neuro-2a cells using Lipofectamine 3000
reagent, with high-GC siRNA (Invitrogen) as the negative
control. SiRNA transfection efficiency was tested by transfecting
Alexa fluor 555-labeled scrambled siRNA (Invitrogen) into
Neuro-2a cells (Supplementary Figure S2A). Three siRNA
candidates were employed under the same transfection protocol
(Supplementary Figure S2B).
Western Blotting
Protein samples were lysed in RIPA buffer with a protease
inhibitor cocktail (Sangon) and 1 mM phenylmethanesulfonyl
fluoride (Sigma). Proteins were quantified by Bradford protein
assay and separated with 10% SDS-PAGE. Gel separated
proteins were transferred to a PVDF membrane followed by
Western blotting with a primary antibody at 4◦C overnight
and horseradish peroxidase-conjugated secondary antibody for
2 h. Signals were developed with a Western Lightning PLUS kit
(NEL105001EA, PerkinElmer). Optical density was quantified by
Quantity One (Bio-Rad).
Fluorescence Immunostaining and
Image Acquisition
Neurons were fixed in a 4% PFA-PBS solution for 20 min
at room temperature and permeablized and blocked in PBS
containing 1% bovine serum albumin, 4% goat serum and 0.4%
Triton X-100 for 30 min at room temperature. Cells were
stained with primary antibodies at 4◦C overnight followed by
fluorescence–conjugated secondary antibodies for 2 h at room
temperature. Finally, cells were stained with DAPI, washed with
PBS followed by deionized water and mounted with antifade
mounting medium (Beyotime). Images of cortical neurons were
captured by a Zeiss LSM 710 confocal microscope with a 40x
objective, while those of hippocampal neurons were captured
with a Z-stack, followed by maximum intensity projection with
a 40x objective. Images were analyzed with Zen 2012 (Zeiss) and
ImageJ (NIH).
Statistical Analysis
Data are presented as mean ± SEM and as differences among
groups. Figures 3F,4B,C,E,F, and 5B were analyzed by ANOVA
with Bonferroni analysis, while the rest of the data were
analyzed by a two-tailed Student’s t-test. All statistical analyses
were performed by the SPSS Statistics v20.0 and 24 software
package (IBM). P-values < 0.05 were considered statistically
significant.
RESULTS
Identification of Seed lncRNAs in
12-Month-Old APPswe/PS11E9
Transgenic Mice
To identify the potential contribution of lncRNAs in AD, we
conducted whole transcriptome sequencing in cortical samples
of 12-month-old APPswe/PS11E9 transgenic mice. Overall, 47
lncRNAs, 3 mid-size ncRNAs and 286 mRNAs were found to
be differentially expressed in APPswe/PS11E9 cortical samples
compared to WT controls (fold change ≥ ± 1.5, FDR < 0.05)
(Figures 1A–D; Supplementary Tables S2 and S3).
LncRNA–miRNA Interaction Prediction
Given the hypothesis that RNAs may crosstalk through
MREs as an RNA language, we next predicted lncRNA–
miRNA interactions using the DIANA LncBase. Specifically, 47
differentially expressed lncRNA Ensembl gene IDs were inputted
into the DIANA LncBase, and four of them obtained nine
predicting miRNA targets (filter cutoff 0.8). To interrogate the
roles of these predicted target miRNAs in AD pathogenesis,
we utilized a previously published miRNAseq data set of
APPswe/PS11E9 transgenic mice (Luo et al., 2014) and those
with transcripts per million (Tpm) less than 10 were removed.
As a result, we obtained four seed lncRNAs targeting five miRNA
targets (Figure 1E; Supplementary Table S4).
Identification of Potential mRNA Targets
of miRNAs Enriched in Signaling
Pathways and an AD-Related Gene Pool
To further establish the lncRNA-miRNA-mRNA interaction
network, we first searched valid mRNA targets of miRNAs by
TarBase v7.0 with experimental support. We then predicted
potential mRNA targets through the DIANA web server v5.0
with the support of Miranda and TargetScan (filter cutoff
0.9). In total, 1082 mRNA targets were inputted into DAVID
for KEGG pathway analysis, and 173 of them were enriched
in the top eight AD-related pathways as following: adherent
junction, insulin signaling pathway, focal adhesion, neurotrophin
signaling pathway, MAPK signaling pathway, regulation of actin
cytoskeleton (FDR < 0.05, p < 0.05), ErbB signaling pathway,
and long-term potentiation and axon guidance (p < 0.05). Next,
these mRNA targets were screened in the AD-related gene pool
annotated by GeneCards, and 113 genes that were not involved
in KEGG pathways were listed as AD-related genes (Figure 2;
Supplementary Tables S4 and S5).
Construction of the ceRNA Network
Competing endogenous RNA network was constructed to
include 4 seed lncRNAs, 5 miRNAs, and 1082 mRNAs. Moreover,
the top eight enriched AD-related signaling pathways and the
AD-related gene pool were outstanding in the network, except
for focal adhesion, which shared identical genes with the other
pathways. Overall, 1091 nodes with 1117 edges were found. We
found that some mRNAs interact with two or more miRNAs in
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 February 2017 | Volume 10 | Article 27
fnmol-10-00027 February 6, 2017 Time: 18:32 # 5
Cai et al. Rpph1 Regulates Dendritic Spine Formation
FIGURE 1 | Differentially expressed lncRNAs and mRNAs in whole transcriptome sequencing of APPswe/PS11E9 transgenic mouse cortical
samples. Heat maps derived from differentially expressed mRNAs (A) or lncRNAs (B) in cortical samples of 12-month-old APPswe/PS11E9 mice (APP) and
wild-type mice (WT) under unsupervised hierarchical clustering. Upregulated genes are represented in red, while down-regulated genes are represented in green.
(C) Pie chart of differentially expressed lncRNAs, mid-size mRNAs and mRNAs. (D) Volcano plot representing up-regulated (red), down-regulated (green) and not
differentially expressed genes (DEGs) (gray). (A–D) Were screened under the following cutoffs: fold change ≥ ± 1.5 with FDR < 0.05. (E) Flowchart of ceRNA
network construction. (i) Differentially expressed lncRNAs were screened by cutoffs of fold change ≥ ± 1.5 with FDR < 0.05. (ii) lncRNA–miRNA interaction was
predicted by DIANA LncBase. (iii) miRNAs were removed when Tpm was less than 10 in APPswe/PS11E9 miRNAseq. (iv) Potential mRNA targets of miRNAs were
predicted by TarBase v7.0 and the DIANA web server v5.0 with support of TargetScan and Miranda. (v) KEGG analysis was performed among the mRNA targets.
the network and that some mRNAs were enriched in more than
one signaling pathways as well as the AD-related gene pool. To
simplify the network, each mRNA is only shown in one signaling
pathway, and those appear in multiple pathways or in the gene
pool are shown in bold (Figure 2). More detailed information is
shown in Supplementary Tables S4–S6.
Rpph1 Is Upregulated in
APPswe/PS11E9 Mice and by Stressor
Treatments
The expression levels of the four hub lncRNAs in 12-month-
old APPswe/PS11E9 and WT mouse cortical samples were
examined. Expression levels of both Rpph1 and Gm15477 (abbr:
Gm15) were upregulated (Figure 3A). Given the hypothesis
that the more MREs a RNA has the more important role it
may play in the ceRNA network, we further studied Rpph1,
which was predicted to interact with both miR-326-3p and
miR-330-5p. Rpph1 is located on Chr14q11.2 of the mouse
genome (Figure 3B). To study the expression profile of Rpph1,
we tested Rpph1 RNA levels in the organs of three 2-month-
old C57/BL6 mice. Our results showed that Rpph1 is widely
expressed in different organs and is abundantly expressed in the
brain, lung and spleen (Figure 3C), consistent with previously
reports (Ame et al., 2001). In our study, Rpph1 expression level
in the spleen is significantly higher than that in other organs
(ANOVA with Bonferroni analysis, F = 6.496, 0.01 < p < 0.05).
We examined Rpph1 RNA levels in cortical and hippocampal
samples of 9–12-month-old APPswe/PS11E9 and WT mice
using quantitative RT-PCR. Rpph1 level was elevated in both
cortical and hippocampal samples of APPswe/PS11E9 transgenic
mice compared to those of WT mice (Figure 3D). Of note, its
predicted downstream target, Cdc42, was also upregulated in
cortical samples in APPswe/PS11E9 mice compared to those
of WT (Figure 3E). Since multiple cell stressors have been
implicated in the pathogenesis of AD (Tong et al., 2005; Borghi
et al., 2007), we further asked which factors can lead to an
elevation of Rpph1 RNA levels. Differentiated Neuro-2a cells
were exposed to hyperthermia, hydrogen peroxide (H2O2),
high glucose, 1 or 4 µM Aβ 1–42, PBS and ammonium
hydroxide for 12 h. Rpph1 levels were upregulated to 1.37-
and 1.54-fold following exposure to 1 and 4 µM Aβ 1–42,
respectively (Figure 3F), compared to general medium treatment
(control). Similar results were obtained with PBS and 1 mmol/L
ammonium hydroxide treatment. These results suggest that Aβ
1–42 is the major factor reinforcing the upregulation of Rpph1
in AD. Cdc42 showed no significant change in the stressor
test.
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FIGURE 2 | Competing endogenous RNA network in the APPswe/PS11E9 transgenic mouse model. Four lncRNAs (red) and five miRNAs (yellow)
are shown in the center; mRNAs enriched in the top eight KEGG pathways are colored and circled. The rest of the mRNA targets are shown in gray. Edges
representing interactions. AD-related genes enriched in KEGG pathways are shown in bold inside dots and the gene names of gray dots are listed in the
Supplementary Material.
Rpph1 Modulates CDC42 Expression
Level through miR-330-5p
To examine lncRNA–miRNA interactions in the ceRNA network,
we predicted possible MREs in Rpph1 and identified miR-326-
3p and miR-330-5p as potential targets. MiR-330-5p shares
eight nucleotide binding sequences with Rpph1 while miR-326-
3p shares seven nucleotide binding sequences (Figure 4A). We
next cloned WT and mutant Rpph1 into the psiCHECK2 vector.
Plasmids were transfected into HEK 293T cells with empty
psiCHECK2 plasmid as a control. Results from Dual Luciferase
Reporter Assay showed that both miR-326-3p and miR-330-5p
inhibit Rpph1 WT luminescence activity by 20%. The reduction
in luciferase activity was not seen when miRNA binding sequence
was mutated (Figure 4B). No significant difference was observed
between vector control and Rpph1-MUT. These results suggest
that miR-326-3p and miR-330-5p bind to Rpph1.
As one miRNA can target various mRNAs, we searched for
the mutual protein coding mRNA targets of miR-326-3p and
miR-330-5p. Twelve mutual mRNAs were found, among which
Cdc42 and Itga5 were implicated in the regulation of actin
cytoskeleton. MiR-330-5p has been reported to target CDC42
in human breast cancer cell line MT-1 (Jeyapalan et al., 2011)
and colorectal cancer cell SW1116 (Li et al., 2013). Moreover,
CDC42 expression level is upregulated in hippocampal pyramidal
neurons of AD patients (Zhu et al., 2000). To this end, we further
pursued the interaction between Rpph1, miR-326-3p/miR-330-5p
and CDC42. To confirm that miR-326-3p and miR-330-5p target
CDC42 in the neural system, we transfected miRNA mimics and
negative controls into Neuro-2a cells and examined the levels of
CDC42 mRNA and protein. Cdc42 mRNA levels were decreased
by overexpression of miR-330-5p and miR-326-3p to 37.2 and
20%, respectively (Figure 4C). CDC42 protein level was markedly
inhibited by miR-330-5p, while miR-326-3p overexpression did
not show a significantly inhibitive effect (Figure 4D).
We then tested whether Rpph1 could modulate Cdc42 mRNA
and protein levels. To this end, we cloned WT and mutant
Rpph1 sequence into a pcDNA4A vector and transfected these
constructs into Neuro-2a cells. Overexpression of Rpph1 resulted
in significantly elevated level of CDC42 protein (Figure 4F)
without affecting its mRNA level (Figure 4E). Such effect of
increased CDC42 protein was not observed when cells were
transfected with mutant Rpph1 (Figure 4F). These results suggest
that Rpph1 promotes the expression of CDC42 by impeding
miR-330-5p binding. Consistent with this notion, transfection of
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FIGURE 3 | Rpph1 was upregulated in APPswe/PS11E9 mice and when under stressor treatments. (A) Expression level of hub lncRNAs in 12-month-old
APPswe/PS11E9 and WT mouse cortical samples (biological replicates n = 17). (B) Genomic location of Rpph1 and the adjacent protein coding genes. (C) Rpph1
expression profile in adult C57/BL6 mouse tissues. Rpph1 (D) and CDC42 (E) expression level in 9–12-month APPswe/PS11E9 and WT mouse cortices (biological
replicates n = 17) and hippocampal (biological replicates n = 14) samples. (F) qRT-PCR analysis of the Rpph1 and Cdc42 expression levels of stressor treatments in
the Neuro-2a cell line. Different vehicles including culture medium (control), NH4OH and PBS were used as negative controls. Quantitative RT-PCR analyses were
normalized to Gapdh as the internal control. ANOVA with Bonferroni analysis was performed, F = 7.692, ∗∗p < 0.01, ∗p < 0.05.
Rpph1 siRNA resulted in decreased levels of CDC42 mRNA and
protein (Figures 4G,H).
Rpph1 Promotes the Development of
Dendritic Spine Density in Hippocampal
Pyramidal Neurons through Upregulation
of CDC42
As Rpph1 is upregulated in 9–12-month-old APPswe/PS11E9
cortices and hippocampi, we hypothesized that it may influence
neuronal behavior. To investigate whether the elevation of the
Rpph1 level could lead to any phenotypic changes in neuronal
cells, we examined dendritic spine formation in cultured primary
hippocampal pyramidal neurons. DIV9 hippocampal neurons
were co-transfected with pcDNA- Rpph1 and pEGFP and fixed
at DIV15. Dendritic spines that extended 50–150 µm from
the soma were observed by confocal microscopy and counted
as two separate groups: apical dendrites and basal dendrites.
Both apical and basal dendritic spine numbers were increased
following the overexpression of pcDNA- Rpph1 (apical dendritic
spine: 28.34 ± 2.98 versus 16.53 ± 1.48; basal dendritic spine:
29.09 ± 2.43 versus 19.75 ± 1.95, Mean ± SEM, n = 18–
25, ∗∗p < 0.01) (Figures 5A,B). This effect was reversed under
overexpression of pcDNA-Rpph1-mutant (Figures 5A,B). Similar
decrease in dendritic spine formation was observed when we
knocked down Rpph1 using siRNA (Figures 5C,D).
DISCUSSION
Recent studies suggest that RNAs, including lncRNAs, circRNAs,
pseudogenes, and mRNAs (Fatica and Bozzoni, 2014), can
function as miRNA sponges (Cesana et al., 2011; Kallen et al.,
2013; Wang et al., 2013) and endogenously compete with each
other through MREs to modulate disease processes (Salmena
et al., 2011; Tay et al., 2014), including that of AD (Faghihi
et al., 2008; Mercer et al., 2009; Esteller, 2011). Apart from
post-transcriptional regulation, epigenetic modifications, such as
histone acetylation, also pose a critical role in AD pathogenesis
(Chouliaras et al., 2010; Rudenko and Tsai, 2014), making AD
a highly complex disease to study. These refined regulatory
networks may explain why the isolation of a single component
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FIGURE 4 | Targeting the expression of Rpph1 and CDC42 by miR-326-3p and miR-330-5p. (A) Predicted binding sequences of miR-326-3p and
miR-330-5p to Rpph1 and CDC42 are shown in bold, as are the mutated sequences in the seed region of Rpph1. (B) Relative Renilla/luciferase luminescence of a
psiCHECK2 vector construct harboring Rpph1 or mutant Rpph1 co-transfected with miR-326-3p/miR-330-5p in the HEK 293T cells, with empty psiCHECK2 vector
as control. Under the condition of overexpression of miR-326-3p, p (vector/Rpph1-WT) = 0.009, p (Rpph1-WT/Rpph1-MUT) = 0.004, F = 13.048, while under the
condition of overexpression of miR-330-5p, p (vector/Rpph1-WT) = 0.033, p (Rpph1-WT/Rpph1-MUT) = 0.005, F = 9.518. The data were analyzed by ANOVA with
Bonferroni analysis. Relative CDC42 mRNA (C) or protein (D) levels in the Neuro-2a cell line following overexpression of miR-326-3p or miR-330-5p mimic
compared to the negative control. Relative CDC42 mRNA (E) or protein (F) levels in the neuro-2a cells following overexpression of Rpph1. P (wt/control) = 0.006, p
(wt/mutant) = 0.023, F = 8.066. Relative Rpph1 and Cdc42 mRNA levels (G) or CDC42 protein levels (H) were determined following transfection of siRNA-Rpph1 or
control siRNA in Neuro-2a cells. Quantitative RT-PCR and Western blotting in (C–F) were normalized to β-actin or GAPDH. Three independent experiments were
performed in all tests. ∗∗p < 0.01, ∗p < 0.05.
(e.g., β-secretase and apolipoprotein E4) failed to fully explain the
whole pathogenesis process of AD (Mullane and Williams, 2013;
Spinney, 2014). In this study, we constructed the first AD-related
ceRNA network based on the APPswe/PS11E9 transgenic mouse
model. A number of AD-related genes were also found in the
ceRNA network. Taken together, our analysis suggests potential
pathways in a comprehensive ceRNA network, which sheds light
on the unknown regulatory pathways in AD. To obtain a better
robustness and reliability of the network, we strictly restrained
the cutoff values for gene entities and screened mRNA candidates
using multiple databases with validated experimental supports.
Nonetheless, imperfections still remain in the lncRNA–miRNA
interaction prediction databases. For example, a considerable
amount of lncRNA inputs did not link with miRNA outputs,
which could lower the network’s sensitivity. It is noteworthy that
the expression levels of both miR-326-3p and miR-330-5p did
not change significantly compared to our previous microRNA-
seq study (Luo et al., 2014). In a ceRNA pathway, microRNAs
act as mediators between upstream and downstream RNAs, either
markedly increasing or decreasing microRNA levels, which may
disrupt the balance of ceRNA crosstalk.
Rpph1 is well-known as an RNA subunit of RNase P, which is
responsible for tRNA maturation in all three domains of life: from
Achaea to Bacteria and Eukarya (Evans et al., 2006). Rpph1 has
also been used to as an internal control for RNA quantification
(Raoul et al., 2005; Page et al., 2011; Soler-Alfonso et al., 2014)
However, recent deep sequencing studies showed that Rpph1 was
up-regulated in the human gastric cancer tissues (Xia et al., 2014)
and in the neocortex of seizure patients (Lipovich et al., 2012),
as well as in cortical samples from the APPswe/PS11E9 mice.
Moreover, a biochemical study has shown that RNase P takes part
in lncRNA MALAT1 maturation (Tripathi et al., 2010). The data
suggest that Rpph1 may be involved in the processes of disease
progression in animals and humans.
Cell division cycle 42 is a member of the Rho family small
guanosine triphosphatases (GTPases) that are involved in cell
morphology, migration, and cell cycle progression (Nobes and
Hall, 1995; Qiu et al., 1997; Hall, 1998). Multiple lines of
evidence show that elevated CDC42 in neurons promotes neurite
outgrowth and dendritic spine formation (Brown et al., 2000;
Kreis et al., 2007). Synaptic strength and neuronal functions
are largely influenced by the size and number of dendritic
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FIGURE 5 | Rpph1 enhances dendritic spine density in hippocampal pyramidal neurons. Apical and basal dendritic spines that extended 50–150 µm of the
soma were observed in pyramidal neurons (A,C). The average dendritic spine number per 100 µm of dendrites was shown following overexpression of WT or
mutant Rpph1 (B) or knocking down of Rpph1 (D) in both the apical and basal dendrites of mouse hippocampal pyramidal neurons. (A,B) Apical dendritic spine: p
(wt/control) = 0.001, p (wt/mutant) = 0.027, F = 8.385; basal dendritic spine: p (wt/control) = 0.018, p (wt/mutant) = 0.45, F = 4.022). (C,D) p (apical) = 0.042, p
(basal) = 0.002. Scale bar = 5 µm, 10–15 transfected neurons were randomly selected in each experiment. Three independent experiments were performed.
∗∗p < 0.01, ∗p < 0.05.
spines (Penzes and Vanleeuwen, 2011). Notably, researchers have
found that CDC42 is upregulated in the hippocampal neurons
of Alzheimer’s patients compared to age-matched controls (Zhu
et al., 2000).
Synaptic scaling is a compensatory homeostatic mechanism in
order to maintain the excitatory response of individual neurons
by preventing the catastrophic amnesia associated with synaptic
loss during AD progression. This process involves alterations
in both neuronal excitability and dendritic architecture (Small,
2004; Abuhassan et al., 2014). Synapse loss is frequently observed
in the postmortem brain tissues of AD patients (Scheff et al., 1990;
Penzes and Vanleeuwen, 2011). Interestingly, neuropathological
studies also found that compensatory changes occurring in AD
brains. An example is such changes is the enlargement of the
remaining dendritic spines and the consequent maintenance of
total synaptic contact area (Scheff and Price, 1993; Fiala et al.,
2002). Our study shows that Rpph1 enhances the expression level
of CDC42 and promotes dendritic spine formation by competing
for endogenously expressed miR-330-5p. This regulatory loop
represents a potential compensatory mechanism in the early stage
of AD pathogenesis (Penzes and Vanleeuwen, 2011; Guo et al.,
2013).
CONCLUSION
We constructed the first ceRNA network based on the
APPswe/PS11E9 transgenic mouse model. We propose that one
of our tested ceRNA pathways, Rpph1/miR-330-5p/CDC42, may
be involved in the compensatory behavior of the brain neurons
to combat synaptic loss during AD pathogenesis. These findings
provide further insight into the pathophysiological mechanism
of AD.
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